RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      Dose ranging study of lutein supplementation in elderly with and without age related macular degeneration.

      한글로보기

      https://www.riss.kr/link?id=T10599960

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      소속기관이 구독 중이 아닌 경우 오후 4시부터 익일 오전 9시까지 원문보기가 가능합니다.

      부가정보

      다국어 초록 (Multilingual Abstract)

      Age-related macular degeneration (AMD) is the leading cause of blindness among people over the age of 65. Epidemiological studies have indicated that people with a high intake of two dietary carotenoids, lutein and zeaxanthin that accumulate in the human macula, are at a reduced risk of AMD. Possible role of lutein and zeaxanthin in the prevention of AMD has been attributed to their antioxidant function and their ability to act as optical filters. The objectives of this study were to investigate the association between three doses of orally ingested lutein supplements and serum levels of this carotenoid in elderly with and without AMD: to evaluate the possible interaction between supplemental lutein and other dietary carotenoids, retinol, alpha- and gamma-tocopherol; to correlate the serum levels of lutein with the total macular pigment optical density (MPOD).
      Forty-five subjects over the age of 60 were divided into 3 groups: subjects without AMD and subjects with middle and end stage of AMD. Subjects in each group were randomized to receive one of the three doses of 2.5, 5, and 10 mg/day of lutein (containing 5% zeaxanthin) for 6 months. Subjects were followed up for 6 months. Carotenoids and their metabolites in the serum of subjects were analyzed by HPLC at weeks 0, 1, 4, 12, 26, 38, and 52. The MPOD of subjects was measured by Heterochromatic Flicker Photometry (HCFP). The data were analyzed using analysis of variance and covariance with repeated measurements (SAS, version 8.2).
      The mean serum concentrations of lutein in all subjects increased with supplementation. Subjects receiving 10 mg/day of lutein had a 3--4 fold increase in their serum levels of lutein, while those receiving 2.5 and 5 mg/day dose had approximately 2 fold increase. In conclusion, the serum concentration of lutein appears to be dose dependent and the presence or the absence of AMD does not interfere with the serum levels of this carotenoid. Supplemental lutein does not interact with other dietary carotenoids, retinol, alpha- and gamma-tocopherol. The results from MPOD measurements by HCFP were inconsistent and could not be used to reach any conclusion with regard to MPOD changes.
      번역하기

      Age-related macular degeneration (AMD) is the leading cause of blindness among people over the age of 65. Epidemiological studies have indicated that people with a high intake of two dietary carotenoids, lutein and zeaxanthin that accumulate in the h...

      Age-related macular degeneration (AMD) is the leading cause of blindness among people over the age of 65. Epidemiological studies have indicated that people with a high intake of two dietary carotenoids, lutein and zeaxanthin that accumulate in the human macula, are at a reduced risk of AMD. Possible role of lutein and zeaxanthin in the prevention of AMD has been attributed to their antioxidant function and their ability to act as optical filters. The objectives of this study were to investigate the association between three doses of orally ingested lutein supplements and serum levels of this carotenoid in elderly with and without AMD: to evaluate the possible interaction between supplemental lutein and other dietary carotenoids, retinol, alpha- and gamma-tocopherol; to correlate the serum levels of lutein with the total macular pigment optical density (MPOD).
      Forty-five subjects over the age of 60 were divided into 3 groups: subjects without AMD and subjects with middle and end stage of AMD. Subjects in each group were randomized to receive one of the three doses of 2.5, 5, and 10 mg/day of lutein (containing 5% zeaxanthin) for 6 months. Subjects were followed up for 6 months. Carotenoids and their metabolites in the serum of subjects were analyzed by HPLC at weeks 0, 1, 4, 12, 26, 38, and 52. The MPOD of subjects was measured by Heterochromatic Flicker Photometry (HCFP). The data were analyzed using analysis of variance and covariance with repeated measurements (SAS, version 8.2).
      The mean serum concentrations of lutein in all subjects increased with supplementation. Subjects receiving 10 mg/day of lutein had a 3--4 fold increase in their serum levels of lutein, while those receiving 2.5 and 5 mg/day dose had approximately 2 fold increase. In conclusion, the serum concentration of lutein appears to be dose dependent and the presence or the absence of AMD does not interfere with the serum levels of this carotenoid. Supplemental lutein does not interact with other dietary carotenoids, retinol, alpha- and gamma-tocopherol. The results from MPOD measurements by HCFP were inconsistent and could not be used to reach any conclusion with regard to MPOD changes.

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼